SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 223 filers reported holding SEATTLE GENETICS INC in Q3 2015. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $325,000 | +72.9% | 1,911 | +17.5% | 0.01% | +75.0% |
Q1 2020 | $188,000 | -19.7% | 1,627 | -49.2% | 0.00% | -20.0% |
Q1 2019 | $234,000 | -53.3% | 3,201 | -50.8% | 0.01% | -54.5% |
Q3 2018 | $501,000 | +19.0% | 6,500 | -17.3% | 0.01% | +10.0% |
Q4 2017 | $421,000 | -1.6% | 7,861 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $428,000 | +5.2% | 7,861 | 0.0% | 0.01% | +11.1% |
Q2 2017 | $407,000 | -17.6% | 7,861 | 0.0% | 0.01% | -18.2% |
Q1 2017 | $494,000 | -37.5% | 7,861 | -55.3% | 0.01% | -42.1% |
Q4 2015 | $790,000 | -2.0% | 17,600 | -15.8% | 0.02% | -5.0% |
Q3 2015 | $806,000 | – | 20,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,046,060 | $2,892,270,000 | 23.68% |
Lagoda Investment Management, L.P. | 88,615 | $5,021,000 | 8.38% |
Matrix Capital Management Company, LP | 3,141,852 | $178,017,000 | 5.90% |
Opus Point Partners Management, LLC | 19,127 | $1,084,000 | 2.39% |
EMORY UNIVERSITY | 41,539 | $2,354,000 | 1.86% |
Capital International Sarl | 238,100 | $13,491,000 | 1.62% |
Rhenman & Partners Asset Management AB | 242,198 | $13,723,000 | 1.57% |
CAPITAL GUARDIAN TRUST CO | 1,341,050 | $75,984,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 42,500 | $1,890,000 | 1.17% |
JGP Global Gestao de Recursos Ltda. | 16,524 | $936,000 | 1.14% |